Our recent study demonstrated downregulated Klotho expression in CKD, while decreased sKlotho expression increased the risk of creatinine doubling or renal replacement therapy in advanced CKD patients (Liu et al., 2018). The gene discussed is KL; the disease is chronic kidney disease.